@article{6c9f51ec8f5f404887ed44fd0f8f43d3,
title = "A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).",
keywords = "OPEN-LABEL TRIAL, TREATED PATIENTS, GLYCEMIC CONTROL, NON-INFERIORITY, PARALLEL-GROUP, LIRAGLUTIDE, METFORMIN, MELLITUS, ASSOCIATION, EXENATIDE",
author = "Dungan, {K M} and Raimund Weitgasser and {Perez Manghi}, F and E Pintilei and Fahrbach, {J L} and Jiang, {H H} and J Shell and Robertson, {K E}",
note = "[Weitgasser, R.] Paracelsus Med Univ, Salzburg Univ Hosp, Dept Med 1, Salzburg, Austria;",
year = "2016",
doi = "10.1111/dom.12634",
language = "English",
volume = "18",
pages = "475--482",
journal = "DIABETES OBESITY & METABOLISM ",
issn = "1462-8902",
publisher = "Wiley Verlag ",
number = "5",
}